Skip header and navigation
Did you mean manic?

Narrow By

18 records – page 1 of 1.

Aripiprazole (Abilify, Abilify Maintena)

https://libcat.nshealth.ca/en/permalink/chpams35626
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1627
Available Online
View Pamphlet
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Aripiprazole
Subjects (LCSH)
Antipsychotic drugs
Specialty
Medications
Abstract
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1627
Less detail

Bipolar disorder

https://libcat.nshealth.ca/en/permalink/chpams34642
Nova Scotia Health Authority. Mental Health and Addictions Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0761
Available Online
View Pamphlet
People with bipolar disorder have periods when their mood is very high or very low. These episodes may last for several days, weeks, or months. In between these episodes, the person’s mood may be normal. The period of very high mood and other symptoms is called mania. The period of very low mood and other symptoms is called depression. This pamphlet explains what causes bipolar disorder, what the symptoms of mania and depression are, how bipolar disorder is treated, and where you can get help.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Mental Health and Addictions Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Bipolar Disorder
Mental Disorders
Subjects (LCSH)
Manic-depressive illness
Mental illness
Specialty
Psychiatry
Abstract
People with bipolar disorder have periods when their mood is very high or very low. These episodes may last for several days, weeks, or months. In between these episodes, the person’s mood may be normal. The period of very high mood and other symptoms is called mania. The period of very low mood and other symptoms is called depression. This pamphlet explains what causes bipolar disorder, what the symptoms of mania and depression are, how bipolar disorder is treated, and where you can get help.
Responsibility
Prepared by: Mental Health and Addictions Program
Pamphlet Number
0761
Less detail

Bipolar disorders : mixed states, rapid cycling and atypical forms

https://libcat.nshealth.ca/en/permalink/provcat27229
edited by Andreas Marneros and Frederick K. Goodwin. --Cambridge, UK: Cambridge University Press , c2005.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Marneros, A
Other Authors
Goodwin, Frederick K
Responsibility
edited by Andreas Marneros and Frederick K. Goodwin
Place of Publication
Cambridge, UK
Publisher
Cambridge University Press
Date of Publication
c2005
Physical Description
395 p.
ISBN
9786610231522 (electronic bk.)
Subjects (MeSH)
Bipolar Disorder
Contents
Cover -- Half-title -- Title -- Copyright -- Contents -- Contributors -- Preface -- 1 Bipolar disorders beyond major depression and euphoric mania -- Introduction: knowledge from the past, goals for the future -- Mixed states -- The ancient times -- From Heinroth to the psychopharmacological revolution -- The renaissance of mixed states -- Frequency -- Phenomenology -- Onset, course, and outcome -- Comorbidity -- Family history -- Treatment -- Future perspectives on mixed states -- Rapid cycling -- Age at onset -- Family studies and genetics -- Biological data -- Comorbidity -- Longitudinal prognosis -- Treatment -- Bipolar schizoaffective mixed states -- Atypical depressions -- Polymorphic psychotic disorders as a possible atypical bipolar disorder -- Lessons from the past and options for the future -- REFERENCES -- 2 Emerging concepts of mixed states: a longitudinal perspective -- Definition of bipolar mixed states -- Dysphoric mania -- Toward a broader definition of mixed mania -- Depressive mixed states -- Bipolar II and unipolar depressive mixed states -- Long-term aspects of mixed states -- Conclusions -- REFERENCES -- 3 Rapid-cycling bipolar disorder -- Introduction -- Family genetics -- Pathophysiology -- Epidemiology, phenomenology, and comorbidity -- Pharmacotherapy -- Treatment recommendations -- Lamotrigine -- Clinical response -- Lithium -- Divalproex sodium -- Olanzapine -- Quetiapine -- Combination therapy -- REFERENCES -- 4 Bipolar I and bipolar II: a dichotomy? -- Introduction -- Is there a true dichotomy between bipolar I and bipolar II disorder? -- Epidemiologic studies -- Age at onset -- Clinical course and outcome -- Pathophysiology -- Family studies and genetics -- Neuroimage -- Neurochemical studies -- Neurophysiology -- Treatment -- Conclusion -- Acknowledgments -- REFERENCES -- 5 Recurrent brief depression as an indicator of severe mood disorders -- Introduction -- Bipolar spectrum -- Recurrent brief psychiatric syndromes -- Methodology -- Sample -- Interviews -- Definitions -- Bipolar spectrum -- Depressive spectrum -- Recurrent brief psychiatric syndromes -- Combined syndromes -- Rapid cycling and seasonality -- Treatment and distress -- Personality -- Statistics -- Results -- Recurrent brief psychiatric syndromes and their overlap -- The value of RBD, RBM, and hypomanic symptoms as a predictor of BP-II disorder -- Combined versus pure mood disorders (Table 5.2) -- Gender -- Diagnostic overlap -- Family history -- Clinical characteristics -- Onset and course -- Associations with other psychiatric disorders -- Personality -- Suicide attempts -- Discussion -- Prevalence -- Comorbidity -- Risk of suicide attempts -- What is the nature of RBD? -- Treatment of RBD and CD -- Conclusion -- Acknowledgment -- REFERENCES -- 6 Atyp
Format
e-Book
Location
Online
Less detail

Clinical handbook for the management of mood disorders

https://libcat.nshealth.ca/en/permalink/provcat33198
edited by J. John Mann, Patrick J. McGrath, Steven P. Roose. --Cambridge, UK: Cambridge University Press , c2013.
Available Online
View e-Book
Location
Online
"This Clinical Handbook for the Management of Mood Disorders will equip clinicians with the knowledge to refine their diagnostic skills and implement treatment plans for mood disorders based on the most up-to-date evidence on interventions that work. Covering the widest range of treatments and techniques, it provides clear guidance for the management of all types and subtypes of both minor and major depression. Chapters cover the latest and most innovative treatments, including use of ketamine,…
Available Online
View e-Book
Other Authors
Mann, J. John
Roose, Steven P
McGrath, Patrick J
Responsibility
edited by J. John Mann, Patrick J. McGrath, Steven P. Roose
Place of Publication
Cambridge, UK
Publisher
Cambridge University Press
Date of Publication
c2013
Physical Description
1 online resource, 417 p.
Series Title
Cambridge medicine
ISBN
9781107055636 (electronic bk.)
1107055636 (electronic bk.)
Subjects (MeSH)
Mood Disorders - therapy
Behavior Therapy - methods
Subjects (LCSH)
Affective disorders - Handbooks, manuals, etc
Mood Disorders - therapy
Behavior Therapy - methods
Abstract
"This Clinical Handbook for the Management of Mood Disorders will equip clinicians with the knowledge to refine their diagnostic skills and implement treatment plans for mood disorders based on the most up-to-date evidence on interventions that work. Covering the widest range of treatments and techniques, it provides clear guidance for the management of all types and subtypes of both minor and major depression. Chapters cover the latest and most innovative treatments, including use of ketamine, deep brain stimulation and transcranial magnetic stimulation, effective integration of pharmacological and psychotherapeutic approaches, as well as providing a thought-provoking look at the future research agenda and the potential for reliable biomarkers. This is the most comprehensive review of depression available today. Written and edited by leading experts mostly from Columbia University, this is an essential resource for anyone involved in the care and treatment of patients with mood disorders"--Provided by publisher.
Contents
Preface -- Part I. Introduction. 1. Models of depression / Steven P. Roose, Patrick J. McGrath and J. John Mann ; 2. Diagnosis of mood disorders / Michael B. First and Jean Endicott ; 3. Dysthymia and chronic depression / David J. Hellerstein and Jordan W. Eipper -- Part II. Medical management. 4. Management of adult major depressive disorder / J. John Mann, Steven P. Roose and Patrick J. McGrath ; 5. Atypical depression / Jonathan W. Stewart ; 6. Psychotic depression / Barnett S. Meyers and Jimmy N. Avari ; 7. Pharmacologic and somatic treatments for bipolar depression / Lucas Giner, S. Aiden Kelly and Maria A. Oquendo ; 8. Medication treatment of mania: acute and preventive / David A. Kahn ; 9. Treatment of mood disorders in later life / Steven P. Roose and Devangere P. Devanand ; 10. Chronic depression / James H. Kocsis and Benjamin D. Brody ; 11. Pediatric depression / David A. Brent ; 12. Therapeutics of pediatric bipolar disorder / Robert A. Kowatch, Melissa P. DelBello and Barbara L. Gracious ; 13. Depression in the context of physical illness / Peter A. Shapiro, Philip R. Muskin and Emily Gastelum ; 14. Mood disorders in the context of borderline personality disorder / Eric A. Fertuck, Megan S. Chesin and Barbara H. Stanley ; 15. Depression in the context of pregnancy / Margaret G. Spinelli and Carolyn Broudy ; 16. Depression and the menstrual cycle / Benicio N. Frey, Luciano Minuzzi, Roberto Sassi and Meir Steiner ; 17. Depression in the context of alcoholism and other substance use disorders / Edward V. Nunes, Jr and Frances R. Levin ; 18. Complementary and alternative treatments for mood disorders / Drew Ramsey, M. Elizabeth Sublette and Philip R. Muskin -- Part III. Psychotherapies for mood disorders. 19. Cognitive behavior therapy / Michael E. Thase ; 20. Interpersonal therapy / Myrna M. Weissman, Annie E. Rabinovitch and Helena Verdeli ; 21. Dialectical behavioral therapy for mood disorders / Barbara H. Stanley and Megan S. Chesin ; 22. The psychodynamic treatment of mood disorders / Deborah L. Cabaniss, Diana E. Moga and Aerin M. Hyun ; 23. Combining medication and psychotherapy in the treatment of depression / Bret R. Rutherford and Steven P. Roose -- Part IV. Specific modalities of treatment. 24. Electroconvulsive therapy / Joshua Berman and Joan Prudic ; 25. Transcranial magnetic stimulation and deep brain stimulation / Sarah H. Lisanby and Moacyr A. Rosa ; 26. Chronotherapeutics: light therapy, wake therapy, and melatonin / Michael Terman and Jiuan Su Terman ; 27. Ketamine in treatment-resistant depression / Kyle Lapidus and Sanjay J. Mathew -- Part V. The promise of biomarkers and response prediction. 28. Brain imaging / Ramin V. Parsey and Martin J. Lan ; 29. Pharmacogenetics and mood disorders / Gonzalo Laje and Francis J. McMahon ; 30. Electrophysiological predictors of clinical response to antidepressants / Gerard E. Bruder, Craig E. Tenke and Jürgen Kayser -- Part VI. Future directions. 31. Future directions / Patrick J. McGrath, Steven P. Roose and J. John Mann -- Index.
Format
e-Book
Location
Online
Less detail

Clinical handbook for the management of mood disorders

https://libcat.nshealth.ca/en/permalink/provcat26322
edited by J. John Mann, Patrick J. McGrath, Steven P. Roose. --Cambridge, UK: Cambridge University Press , c2013.
Call Number
WM 171 C641 2013
Location
Halifax Infirmary
Nova Scotia Hospital
"This Clinical Handbook for the Management of Mood Disorders will equip clinicians with the knowledge to refine their diagnostic skills and implement treatment plans for mood disorders based on the most up-to-date evidence on interventions that work. Covering the widest range of treatments and techniques, it provides clear guidance for the management of all types and subtypes of both minor and major depression. Chapters cover the latest and most innovative treatments, including use of ketamine…
Call Number
WM 171 C641 2013
Other Authors
Mann, J John
McGrath, Patrick J
Roose, Steven P
Responsibility
edited by J. John Mann, Patrick J. McGrath, Steven P. Roose
Place of Publication
Cambridge, UK
Publisher
Cambridge University Press
Date of Publication
c2013
Physical Description
417 p.
Series Title
Cambridge medicine
ISBN
9781107024632
Subjects (MeSH)
Behavior Therapy - methods
Mood Disorders - therapy
Abstract
"This Clinical Handbook for the Management of Mood Disorders will equip clinicians with the knowledge to refine their diagnostic skills and implement treatment plans for mood disorders based on the most up-to-date evidence on interventions that work. Covering the widest range of treatments and techniques, it provides clear guidance for the management of all types and subtypes of both minor and major depression. Chapters cover the latest and most innovative treatments, including use of ketamine, deep brain stimulation and transcranial magnetic stimulation, effective integration of pharmacological and psychotherapeutic approaches, as well as providing a thought-provoking look at the future research agenda and the potential for reliable biomarkers. This is the most comprehensive review of depression available today. Written and edited by leading experts mostly from Columbia University, this is an essential resource for anyone involved in the care and treatment of patients with mood disorders"--Provided by publisher.
Contents
Preface; Part I. Introduction: 1. Models of depression Steven P. Roose, Patrick J. McGrath and J. John Mann; 2. Diagnosis of mood disorders Michael B. First and Jean Endicott; 3. Dysthymia and chronic depression David J. Hellerstein and Jordan W. Eipper; Part II. Medical Management: 4. Management of adult major depressive disorder J. John Mann, Steven P. Roose and Patrick J. McGrath; 5. Atypical depression Jonathan W. Stewart; 6. Psychotic depression Barnett S. Meyers and Jimmy N. Avari; 7. Pharmacologic and somatic treatments for bipolar depression Lucas Giner, S. Aiden Kelly and Maria A. Oquendo; 8. Medication treatment of mania: acute and preventive David A. Kahn; 9. Treatment of mood disorders in later life Steven P. Roose and Devangere P. Devanand; 10. Chronic depression James H. Kocsis and Benjamin D. Brody; 11. Pediatric depression David A. Brent; 12. Therapeutics of pediatric bipolar disorder Robert A. Kowatch, Melissa P. DelBello and Barbara L. Gracious; 13. Depression in the context of physical illness Peter A. Shapiro, Philip R. Muskin and Emily Gastelum; 14. Mood disorders in the context of borderline personality disorder Eric A. Fertuck, Megan S. Chesin and Barbara H. Stanley; 15. Depression in the context of pregnancy Margaret G. Spinelli and Carolyn Broudy; 16. Depression and the menstrual cycle Benicio N. Frey, Luciano Minuzzi, Roberto Sassi and Meir Steiner; 17. Depression in the context of alcoholism and other substance use disorders Edward V. Nunes, Jr and Frances R. Levin; 18. Complementary and alternative treatments for mood disorders Drew Ramsey, M. Elizabeth Sublette and Philip R. Muskin; Part III. Psychotherapies for Mood Disorders: 19. Cognitive behavior therapy Michael E. Thase; 20. Interpersonal therapy Myrna M. Weissman, Annie E. Rabinovitch and Helena Verdeli; 21. Dialectical behavioral therapy for mood disorders Barbara H. Stanley and Megan S. Chesin; 22. The psychodynamic treatment of mood disorders Deborah L. Cabaniss, Diana E. Moga and Aerin M. Hyun; 23. Combining medication and psychotherapy in the treatment of depression Bret R. Rutherford and Steven P. Roose; Part IV. Specific Modalities of Treatment: 24. Electroconvulsive therapy Joshua Berman and Joan Prudic; 25. Transcranial magnetic stimulation and deep brain stimulation Sarah H. Lisanby and Moacyr A. Rosa; 26. Chronotherapeutics: light therapy, wake therapy, and melatonin Michael Terman and Jiuan Su Terman; 27. Ketamine in treatment-resistant depression Kyle Lapidus and Sanjay J. Mathew; Part V. The Promise of Biomarkers and Response Prediction: 28. Brain imaging Ramin V. Parsey and Martin J. Lan; 29. Pharmacogenetics and mood disorders Gonzalo Laje and Francis J. McMahon; 30. Electrophysiological predictors of clinical response to antidepressants Gerard E. Bruder, Craig E. Tenke and Jürgen Kayser; Part VI. Future Directions: 31. Future directions Patrick J. McGrath, Steven P. Roose and J. John Mann; Index.
Format
Book
Location
Halifax Infirmary
Nova Scotia Hospital
Copies
2
Loan Period
3 weeks
Less detail

Clinical psychopharmacology : a practical approach

https://libcat.nshealth.ca/en/permalink/provcat31339
Humberto Marin, Javier I Escóbar. --Hackensack, NJ: World Scientific Pub. Co , c2013.
Available Online
View e-Book
Location
Online
This book aims to provide comprehensive, up-to-date information on psychotropic drugs and inform clinical decisions for the treatment of mental disorders using a problem-solving approach. In order to accomplish these goals, the book has three central characteristics: it is evidence-based; it compares each individual drug with others in the same class and also those used for the same indications rather than describing them separately; it steadily draws practical conclusions and makes recommendat…
Available Online
View e-Book
Author
Marin, Humberto
Other Authors
Escóbar, Javier I
Responsibility
Humberto Marin, Javier I Escóbar
Place of Publication
Hackensack, NJ
Publisher
World Scientific Pub. Co
Date of Publication
c2013
Physical Description
1 online resource (286 p.)
ISBN
9789814343664
Subjects (MeSH)
Mental Disorders - drug therapy
Psychopharmacology
Psychotropic Drugs
Abstract
This book aims to provide comprehensive, up-to-date information on psychotropic drugs and inform clinical decisions for the treatment of mental disorders using a problem-solving approach. In order to accomplish these goals, the book has three central characteristics: it is evidence-based; it compares each individual drug with others in the same class and also those used for the same indications rather than describing them separately; it steadily draws practical conclusions and makes recommendations about how to select and use medications in the treatment of specific mental disorders. More than a textbook, it is meant to serve as a practical tool for professionals working in the mental health field.
Contents
Ch. 1. Absorption, transformation, and elimination of psychotropic medications. -- ch. 2. Neurotransmitters, receptors, and transporters. 2.1. Main types of receptors in the brain. 2.2. Neurotransmitters. 2.3. Neurotransmitter reuptake transporters -- ch. 3. Antipsychotics: a general view of therapeutic and adverse effects. 3.1. Classic antipsychotics. 3.2. New antipsychotics. 3.3. Are the new antipsychotics clinically different from the old ones? 3.4. Current concepts regarding antipsychotic action and the D[symbol] receptor. 3.5. Comparison between typical and atypical antipsychotics. 3.6. Metabolic side effects of antipsychotic drugs. 3.7. Extrapyramidal symptoms of antipsychotics. 3.8. Neuroleptic malignant syndrome. 3.9. Catatonia. 3.10. Antipsychotic-induced hyperprolactinemia. 3.11. Sexual side effects of antipsychotics. 3.12. Antihistamine adverse effects of antipsychotics. 3.13. Anticholinergic adverse effects of antipsychotics: cognitive and peripheral. 3.14. Antipsychotics and the risk of seizures. 3.15. Vascular side effects of antipsychotics. 3.16. Antipsychotics and the risk of malignant arrythmia and sudden cardiac death. 3.17. Antipsychotics and increased morbidity and mortality in patients with dementia. 3.18. Antipsychotics and suicide. 3.19. Antipsychotics and the risk of cancer -- ch. 4. Description of individual antipsychotics. 4.1. Typical antipsychotics. 4.2. Atypical antipsychotics -- ch. 5. Treatment of schizophrenia with antipsychotic medications. 5.1. Choice of an antipsychotic for the initial treatment of schizophrenia. 5.2. Dosing in the initial antipsychotic treatment of schizophrenia. 5.3. How long does it take to respond to an antipsychotic? 5.4. Monitoring antipsychotic treatment. 5.5. Maintenance of antipsychotic treatment of schizophrenia. 5.6. Combination of antipsychotic drugs in schizophrenia ("polypharmacy"). 5.7. Pharmacological management of treatment-resistant schizophrenia. 5.8. Use of long-acting injectable antipsychotics in schizophrenia -- ch. 6. Antidepressants: selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. 6.1. Introduction. 6.2. Pharmacodynamics of SSRIs and SNRIs (receptor affinity). 6.3. Pharmacokinetics of SSRIs and SNRIs. 6.4. Use of SSRIs in mental disorders. 6.5. Use of SNRIs in mental disorders. 6.6. Dosing of SSRIs and SNRIs. 6.7. Adverse effects of SSRIs and SNRIs. 6.8. Discontinuation syndrome with SSRIs and SNRIs. 6.9. Toxicity of SSRIs and SNRIs and serotonin syndrome. 6.10. Precautions with SSRIs and SNRIs. 6.11. Use of SSRIs and SNRIs during pregnancy and lactation -- ch. 7. Bupropion. 7.1. Introduction. 7.2. Pharmacology. 7.3. Approved indications and other possible uses. 7.4. Dosing and available forms of bupropion. 7.5. Side effects and adverse reactions. 7.6. Contraindications, warnings, and precautions. 7.7. Use of bupropion during pregnancy -- Ch. 8. Mirtazapine, trazodone, and nefazodone. 8.1. Mirtazapine. 8.2. Trazodone. 8.3. Nefazodone -- ch. 9. Monoamine oxidase inhibitors and tricyclic antidepressants. 9.1. Monoamine oxidase inhibitors. 9.2. Tricyclic antidepressants -- ch. 10. Individualized treatment of depression. 10.1. Patient factors to consider. 10.2. Second-generation antidepressants: doses and duration. 10.3. Hypnotics and other symptom-specific medications. 10.4. Partial response to antidepressant treatment: what to do? 10.5. No response to initial antidepressant treatment: what to do? 10.6. What about adding atypical antipsychotics in the initial treatment of depression? 10.7. Other non-antidepressant drugs recently tried in depression. 10.8. Once the patient gets better, how to stop antidepressant treatment? -- ch. 11. Benzodiazepines, buspirone, and miscellaneous medications used in anxiety disorders. 11.1. Benzodiazepines. 11.2. Buspirone. 11.3. Antiepileptic drugs. 11.4. Antihistamines. 11.5. Prazosin for nightmares in post-traumatic stress disorder. 11.6. Do antipsychotics have a role in anxiety? 11.7. Beta-blockers -- ch. 12. Medication treatment of anxiety disorders. General considerations prior to starting drug treatment. Other considerations. 12.1. Approved and potential uses of antidepressants and other medications. 12.2. Drug treatment of individual anxiety disorders -- ch. 13. Medications used in the treatment of mania. 13.1. Lithium. 13.2. Antipsychotics. 13.3. Carbamazepine. 13.4. Oxcarbazepine. 13.5. Valproic acid (divalproex, valproate). 13.6. Tamoxifen -- ch. 14. Medications used in bipolar depression, mixed states, and rapid cycling. 14.1. Electroconvulsive therapy. 14.2. Lithium. 14.3. Quetiapine. 14.4. Lamotrigine. 14.5. Valproate. 14.6. Antidepressants. 14.7. Ketamine in bipolar and treatment-resistant depression. 14.8. Pharmacological treatment of mixed states and rapid cycling bipolar disorder -- ch. 15. Medications used in the treatment of insomnia. 15.1. General rules. 15.2. Antihistamines as hypnotics. 15.3. Sedating antidepressants (trazodone and mirtazapine). 15.4. Melatonin receptor agonists. 15.5. GABA receptor agonists -- ch. 16. Medications used in the treatment of attention disorders. 16.1. Stimulant medications (psychostimulants). 16.2. Atomoxetine. 16.3. Bupropion. 16.4. Modafinil. 16.5. [symbol]-adrenergic agonists (guanfacine and clonidine) -- ch. 17. Medications used in the treatment of dementia. 17.1. Side effects. 17.2. Pharmacokinetics. 17.3. Pointers for clinical use -- ch. 18. Medications used in smoking cessation and alcohol use disorders. 18.1. Medications used in the treatment of nicotine dependence (smoking cessation). 18.2. Medications used in the treatment of alcohol use disorders -- ch. 19. Drug-drug interactions. 19.1. Pharmacokinetic drug-drug interactions. 19.2. Pharmacodynamic DDIs involving psychotropic drugs. 19.3. Drug-drug Interactions due to cumulative toxicity. 19.4. Drug-drug interactions related to food supplements and substances of abuse.
Format
e-Book
Location
Online
Less detail

Early Career Physician Mental Health and Wellness : A Clinical Casebook

https://libcat.nshealth.ca/en/permalink/provcat44254
Janna S. Gordon-Elliott, Anna H. Rosen, editors. --Cham: Springer , 2019.
Available Online
View e-Book
Location
Online
This casebook tackles the common psychiatric illnesses that physicians experience during these early stages of their careers. The cases carefully present guidelines for assessment and management, along with clinical pearls and resources for further reference. Written by experts in the field, the text is designed to be valuable for physicians engaged in medical education and training, and specifically for the psychiatrists who provide care for other physicians. Each chapter includes a unique cas…
Available Online
View e-Book
Other Authors
Gordon-Elliott, Janna S.
Rosen, Anna H.
Responsibility
Janna S. Gordon-Elliott, Anna H. Rosen, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
2019
Physical Description
1 online resource (xii, 264 p. 3 illus. in color)
ISBN
9783030109523
9783030109516 (Print ed.)
9783030109530 (Print ed.)
Subjects (MeSH)
Burnout, Professional - prevention & control
Physician Impairment - psychology
Physicians - psychology
Specialty
Health Promotion
Physicians
Abstract
This casebook tackles the common psychiatric illnesses that physicians experience during these early stages of their careers. The cases carefully present guidelines for assessment and management, along with clinical pearls and resources for further reference. Written by experts in the field, the text is designed to be valuable for physicians engaged in medical education and training, and specifically for the psychiatrists who provide care for other physicians. Each chapter includes a unique case and discussion. Topics include: onset of a mood and or psychotic disorder, life transitions, trauma in care, physician suicide, anxiety, and other issues that are part of the experience of young adults developing their personal and professional identities. Early Career Physician Mental Health and Wellness is an excellent guide for all physicians interested in mental health and wellness, including psychiatrists, psychologists, training directors, hospital leadership, mentors, students, residents, and others.
Contents
The Case of Joseph Martinez: A Medical Student with Mania -- The Case of Monica Khuma: More than Borderline Difficulties -- The Case of James Dire: The Problem with Panic -- The Case of Ramona Williams: Losing Touch -- The Case of Daniel Terzi: Trauma in Clinical Care -- The Case of Abigail Nunce: the Weight of Medical Training -- The Case of Dr. Sigi Halsted: Overdose in the O.R -- The Case of Erik Quimby: A Disruptive Physician in Training -- The Case of Tammy Dohada: When a Fellow Resident and Close Friend Commits -- The Case of Ruth Daughtery: Navigating Catastrophic Illness in a Family Member -- The Case of Bianca Cring: Professional Loyalty and Personal Infidelity -- The Case of Anita Rao: Defining a Career and a Self -- The Case of Regan Cooper: Anxiety in a Gay Resident -- The Case of Katherine Moss: Caring for Oneself to Care for Others -- The Case of Simona Moya: Patient Death and Support for the Doctor -- The Case of Leila Moro: Not Just the Blues -- The Case of Shilpa Shah: The Complexities of Training an Immigrant Physician -- The Case of Edward Thad: An Ethical Dilemma -- The Case of Owen Burt: Running on Empty -- The Case of Jerome Ocean: A Student’s Classic Conundrum.
Format
e-Book
Publication Type
Case Reports
Location
Online
Less detail

The Essential Guide to Lithium Treatment

https://libcat.nshealth.ca/en/permalink/provcat40189
Michael Bauer, Michael Gitlin. --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This book is a practical, up-to-date guide to the correct use of lithium for the short- and long-term treatment of mood disorders. Among the subjects addressed are the pharmacology and mechanisms of action of lithium, its use for maintenance treatment, the role of lithium in the treatment of mania and depression and in suicide prevention, further clinical indications, the administration of lithium during pregnancy and the postpartum period, and adverse effects and their management. Relevant bac…
Available Online
View e-Book
Author
Bauer, Michael
Other Authors
Gitlin, Michael
Responsibility
Michael Bauer, Michael Gitlin
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xiv, 158 p. : 17 illus., 15 illus. in color)
ISBN
9783319312149
9783319312125 (print ed.)
Subjects (MeSH)
Lithium Compounds - therapeutic use
Mood Disorders - drug therapy
Abstract
This book is a practical, up-to-date guide to the correct use of lithium for the short- and long-term treatment of mood disorders. Among the subjects addressed are the pharmacology and mechanisms of action of lithium, its use for maintenance treatment, the role of lithium in the treatment of mania and depression and in suicide prevention, further clinical indications, the administration of lithium during pregnancy and the postpartum period, and adverse effects and their management. Relevant background information is provided on the diagnosis, classification, and natural course of mood disorders, and an overview of other treatments for bipolar disorder and major depression is included. Lithium is the essential medication for patients with mood disorders. The evidence of its efficacy in maintenance treatment is acknowledged in all major international treatment guidelines for bipolar disorders and, when used correctly, lithium unquestionably produces the most dramatic benefits of any medication in psychopharmacology. This essential guide is written by two international experts in the treatment of mood disorders who have more than 25 years of experience in the use of lithium and have authored numerous scientific articles on lithium.
Contents
1. Diagnosis and Classification of Mood Disorders -- 2. Natural Course of Bipolar Disorder and Implications for Treatment -- 3. Lithium and Its History -- 4. What Is Lithium and How Does It Work? -- 5. Maintenance Treatment with Lithium -- 6. Treatment of Mania with Lithium -- 7. Treatment of Depression with Lithium -- 8. Suicide Prevention with Lithium -- 9. Neuroprotection and Other Clinical Indications of Lithium -- 10. Lithium During Pregnancy and in the Postpartum Period -- 11. Practical Management of Lithium -- 12. Adverse Effects of Lithium and Their Management -- 13. Beyond Lithium: Other Treatments for Bipolar Disorder.
Format
e-Book
Location
Online
Less detail

Evidence-based psychopharmacology

https://libcat.nshealth.ca/en/permalink/provcat27253
[edited by] Dan J. Stein, Bernard Lerer, Stephen Stahl. --New York, NY: Cambridge University Press , 2005.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Stein, Dan J
Other Authors
Lerer, Bernard
Stahl, S. M
Responsibility
[edited by] Dan J. Stein, Bernard Lerer, Stephen Stahl
Place of Publication
New York, NY
Publisher
Cambridge University Press
Date of Publication
2005
Physical Description
xviii, 362 p.
ISBN
6610458103 (electronic bk.)
Subjects (MeSH)
Mental Disorders - drug therapy
Psychotropic Drugs - therapeutic use
Psychopharmacology - methods
Evidence-Based Medicine
Contents
Cover -- Half-title -- Title -- Copyright -- Contents -- List of Contributors -- Preface -- REFERENCES -- Introduction -- What is evidence-based medicine? -- Guidelines and algorithms -- What is the evidence for evidence-based medicine? -- REFERENCES -- 1 Evidence-based pharmacotherapy of major depressive disorder -- What is the first-line pharmacotherapy of MDD? -- SSRIs in MDD -- Dual-and triple-action agents and RIMAs in MDD -- Depressive subtypes, comorbidity, and demographics -- Medical comorbidity -- Axis II comorbidity -- Anxiety disorder comorbidity -- Major depressive subtypes -- Demographics: sex -- Age -- How long should pharmacotherapy of MDD continue? -- What is the best pharmacotherapy approach to resistant MDD? -- Antidepressant switching -- Augmentation -- Conclusion -- REFERENCES -- 2 Evidence-based pharmacotherapy of bipolar disorder -- What is the first-line pharmacotherapy of acute mania? -- Lithium -- Anticonvulsants -- Neuroleptic agents -- Other agents -- ECT -- Summary of acute mania studies -- What is the first-line pharmacotherapy of acute bipolar depression? -- Lithium -- Valproate and carbamazepine -- Lamotrigine -- Other novel anticonvulsants -- Olanzapine -- Other atypical neuroleptic agents -- ECT -- Antidepressants -- Summary of acute bipolar depression studies -- What is the best pharmacotherapy approach to prophylaxis in bipolar disorder? -- Lithium -- Valproate and carbamazepine -- Lamotrigine -- Other novel anticonvulsants -- Typical neuroleptic agents -- Olanzapine -- Other atypical neuroleptic agents -- Other agents -- Standard antidepressants -- ECT -- Novel agents: omega-3 fatty acids, vitamin/mineral supplements -- Rapid-cycling bipolar disorder as a proxy for prophylaxis -- Summary of prophylaxis studies -- Acknowledgments -- REFERENCES -- 3 Evidence-based pharmacotherapy of schizophrenia -- What is the first-line pharmacotherapy of schizophrenia? -- Risperidone -- Olanzapine -- Quetiapine -- Ziprasidone -- Sertindole -- Amisulpride -- Aripiprazole -- Special populations of schizophrenia -- What is the best pharmacotherapy approach to resistant schizophrenia? -- Risperidone -- Olanzapine -- Quetiapine -- Conventional versus atypical antipsychotics:the ongoing debate -- Head-to-head comparisons of atypical antipsychotics -- Focusing on side-effect profiles -- Conclusions -- Statement of interest -- REFERENCES -- 4 Evidence-based pharmacotherapy of generalized anxiety disorder -- What is the first-line pharmacotherapy of GAD? -- Summary of published clinical trials of SSRIs and venlafaxine -- Summary of published clinical trials of other psychotropic compounds -- How long should pharmacotherapy of GAD continue? -- What is the best pharmacotherapy approach to resistant GAD? -- Conclusions -- REFERENCES -- 5 Evidence-based pharmacotherapy of panic disorder -- Introduction -- Diagnosis -- Treatment options -- Pharmacotherapy of PD --tidtid4
Format
e-Book
Location
Online
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1937
Available Online
View Pamphlet
Lithium is a mood stabilizer. It is most often used in bipolar disorder to prevent or treat mania or depression. How your dose of lithium is chosen and symptoms it helps to relieve are reviewed. How quickly it starts working, how long to take it, possible side effects, and other general information about lithium is also given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Lithium - therapeutic use
Bipolar Disorder - drug therapy
Mania - drug therapy
Depression, Bipolar - drug therapy
Subjects (LCSH)
Lithium--Therapeutic use
Manic-depressive illness
Abstract
Lithium is a mood stabilizer. It is most often used in bipolar disorder to prevent or treat mania or depression. How your dose of lithium is chosen and symptoms it helps to relieve are reviewed. How quickly it starts working, how long to take it, possible side effects, and other general information about lithium is also given.
Responsibility
Prepared by: Pharmacy Services, QEII
Pamphlet Number
1937
Less detail

Melancholia : the diagnosis, pathophysiology, and treatment of depressive illness

https://libcat.nshealth.ca/en/permalink/provcat27261
Michael Alan Taylor, Max Fink. --Cambridge, UK: Cambridge University Press , c2006.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Taylor, Michael Alan
Other Authors
Fink, Max
Responsibility
Michael Alan Taylor, Max Fink
Place of Publication
Cambridge, UK
Publisher
Cambridge University Press
Date of Publication
c2006
Physical Description
xv, 544 p.
ISBN
661048032X (electronic bk.)
Subjects (MeSH)
Depressive Disorder
Contents
Cover -- Half-title -- Title -- Copyright -- Contents -- Patient vignettes -- Preface -- NOTES -- Acknowledgments -- 1 Melancholia: a conceptual history -- Origins of the concept -- The psychodynamic interruption -- The recognition of melancholia in psychiatric classification -- NOTES -- 2 Melancholia defined -- Melancholy -- Patient 2.1 -- Patient 2.2 -- Patient 2.3 -- Patient 2.4 -- Manic-depressive illness -- Clinical studies of the bipolar-unipolar dichotomy -- Patient 2.5 -- Antidepressant drug-induced mania -- Bipolar and unipolar conditions genetically overlap -- Conclusion -- Psychotic depression is melancholia -- Historical background -- Mood-congruent and mood-incongruent delusions -- Psychotic depression meets criteria for melancholia -- Patient 2.6 -- Patient 2.7 -- Cotard syndrome as an example of psychotic depression -- Patient 2.8 -- Depression with catatonia or stupor is severe melancholia -- Patient 2.9 -- Patient 2.10 -- Patient 2.11 -- Melancholia defined by a specific event -- Pregnancy-related mood disorders (puerperal depression) -- Patient 2.12 -- Patient 2.13 -- Abnormal bereavement is melancholia -- NOTES -- 3 Defining melancholia by psychopathology -- DSM depression categories and diagnostic criteria -- Classification difficulties -- Diagnostic criteria limitations -- Patient 3.1 -- Industry influence -- Consensus and empirical approaches defining a syndrome -- Expert consensus -- Empirical definition -- Psychopathology data supporting the validity of melancholia -- Pre-1980 literature -- The literature since 1980 -- The nature of melancholia -- Conclusions -- Melancholia is a distinct syndrome -- Melancholia is a specific depressive disorder: -- Melancholia offers a specific paradigm -- NOTES -- 4 Defining melancholia: laboratory tests -- Neuroendocrine measures in mood disorders -- The hypothalamic-pituitary-adrenal axis -- The hypothalamic-pituitary-thyroid axis -- Electrophysiologic measures -- Sleep EEG -- Sleep and neuroendocrine variables -- Conclusions -- NOTES -- 5 Examination for melancholia -- Examination strategy -- Examining mood -- Examining psychomotor functioning -- Examining for vegetative signs -- Examining for psychotic features -- Patient 5.1 -- Examining for suicidal thoughts -- Examining cognition -- Examining for personality disorder -- Rating scales of depression -- The Hamilton Rating Scale for Depression -- The Montgomery-Asberg Depression Rating Scale (MADRS) -- The Beck Depression Inventory (BDI) -- Other rating scales -- Using rating scales -- NOTES -- 6 The differential diagnosis of melancholia -- Non-melancholic depressive mood disorders -- Non-melancholic "major depression" -- Atypical depression -- Seasonal affective disorder -- Dysthymia/minor/brief depression -- Adjustment disorder, depressed type -- Premenstrual dysphoric disorder (PDD) -- Melancholia in children and adolescents -- Melancholia in persons
Format
e-Book
Location
Online
Less detail

Neuropsychiatric Symptoms of Cerebrovascular Diseases

https://libcat.nshealth.ca/en/permalink/provcat40693
José M. Ferro, editor. --London: Springer , c2013.
Available Online
View e-Book
Location
Online
Neuropsychiatric Symptoms of Cerebrovascular Diseases is an up-to-date, comprehensive review of the neuropsychiatry of stroke, by active authorities in the field, with an emphasis on diagnostic and management issues. Neuropsychiatric Symptoms of Cerebrovascular Diseases includes critical appraisal of the methodological aspects and limitations of the current research on the neuropsychiatry of stroke and on unanswered questions/controversies. Pharmacological aspects of management are discussed, t…
Available Online
View e-Book
Other Authors
Ferro, José M
Responsibility
José M. Ferro, editor
Place of Publication
London
Publisher
Springer
Date of Publication
c2013
Physical Description
1 online resource (xiii, 338 p. : ill.)
Series Title
Neuropsychiatric symptoms of neurological disease
ISBN
9781447124283
9781447124276 (print ed.)
ISSN
2196-2898
Subjects (MeSH)
Cerebrovascular Disorders - complications
Cerebrovascular Disorders - psychology
Neurobehavioral Manifestations
Abstract
Neuropsychiatric Symptoms of Cerebrovascular Diseases is an up-to-date, comprehensive review of the neuropsychiatry of stroke, by active authorities in the field, with an emphasis on diagnostic and management issues. Neuropsychiatric Symptoms of Cerebrovascular Diseases includes critical appraisal of the methodological aspects and limitations of the current research on the neuropsychiatry of stroke and on unanswered questions/controversies. Pharmacological aspects of management are discussed, to provide robust information on drug dosages, side effects and interaction, in order to enable the reader to manage these patients more safely. Illustrative cases provide real life scenarios that are clinically relevant and engaging to read. Neuropsychiatric Symptoms of Cerebrovascular Diseases is aimed at neurologists, stroke physicians and psychiatrists, and will also be of interest to intensive care doctors, psychologists ad neuropsychologists, research and specialist nurses, clinical researchers and methodologists.
Contents
Part 1. Psychiatry of Stroke -- Delirium in stroke patients -- Poststroke Illusions and Hallucinations -- Depression after Stroke -- Mania -- Anxiety Disturbances in Stroke Patients -- Apathy -- Disturbances in the voluntary control of emotional expression after stroke -- Poststroke Aggressiveness -- Denial of Illness -- Part II: Psychiatry of Vascular Cognitive Impairment -- Neuropsychiatric Symptoms of CADASIL -- Neuropsychiatric Aaspects of Vascular Cognitive Impairment -- Part III. Cerebrovascular Disease and Psychiatric Disturbances -- Psychological and Psychiatric Triggers and Risk Factors for Stroke -- Vascular Depression -- Cerebrovascular Disease and Bipolar Disorder.
Format
e-Book
Location
Online
Less detail

Neuropsychiatric Symptoms of Epilepsy

https://libcat.nshealth.ca/en/permalink/provcat39868
Marco Mula, editor. (1st ed.) --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This book is an up-to-date, comprehensive review of the neuropsychiatry of epilepsy, by active authorities in the field, with an emphasis on clinical and management issues. A critical appraisal of the methodology and limitations of current research on the neuropsychiatry of epilepsy is provided, and unanswered questions and controversies are addressed. Pharmacological aspects of management are also discussed in order to enable the reader to manage these patients more safely. Neuropsychiatric Sy…
Available Online
View e-Book
Other Authors
Mula, Marco
Responsibility
Marco Mula, editor
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xvii, 378 p. : 25 illus., 10 illus. in color)
Series Title
Neuropsychiatric symptoms of neurological disease
ISBN
9783319221595
9783319221588 (print ed.)
ISSN
2196-2898
Subjects (MeSH)
Epilepsy - diagnosis
Epilepsy - psychology
Mental Disorders - complications
Abstract
This book is an up-to-date, comprehensive review of the neuropsychiatry of epilepsy, by active authorities in the field, with an emphasis on clinical and management issues. A critical appraisal of the methodology and limitations of current research on the neuropsychiatry of epilepsy is provided, and unanswered questions and controversies are addressed. Pharmacological aspects of management are also discussed in order to enable the reader to manage these patients more safely. Neuropsychiatric Symptoms of Epilepsy is aimed at neurologists, epileptologists, psychiatrists and neuropsychiatrists, and will also be of interest to psychologists and neuropsychologists, research and specialist nurses, clinical researchers and methodologists.
Contents
Neurobehavioral Comorbidities of Epilepsy: Lessons from Animal Models -- Depression -- Mania and Elation -- Anxiety -- Delusions and Hallucinations -- Obsessiveness and Viscosity -- Aggressive Behavior -- Epilepsy and Sleep: Close Connections and Reciprocal Influences -- Dissociation -- Consciousness -- Emotion Recognition -- Neuropsychiatric Symptoms in Learning Disability -- Attention, Executive Function and Attention Deficit Hyperactivity Disorder -- Dementia -- Stress and Epilepsy -- Epilepsy in Psychiatric Disorders -- The Role of Epilepsy Surgery -- The Role of Antiepileptic Drugs -- The Role of Stimulation Techniques.
Format
e-Book
Location
Online
Less detail

Olanzapine (Zyprexa, Zyprexa Zydis)

https://libcat.nshealth.ca/en/permalink/chpams35690
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1669
Available Online
View Pamphlet
Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Antipsychotic Agents
Bipolar Disorder - drug therapy
Schizophrenia - drug therapy
Subjects (LCSH)
Antipsychotic drugs
Manic-depressive illness
Schizophrenia--Treatment
Specialty
Medications
Abstract
Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1669
Less detail

Paliperidone (Invega); Paliperidone Palmitate (Invega Sustenna)

https://libcat.nshealth.ca/en/permalink/chpams36494
Nova Scotia Health Authority. QEII. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1938
Available Online
View Pamphlet
Paliperidone is most often used to treat psychosis. It may also be used to treat mania or depression. Symptoms paliperidone helps to relieve are reviewed. How quickly it starts working, how long to take it, possible side effects, and other general information is also given.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Paliperidone Palmitate - therapeutic use
Psychotic Disorders - drug therapy
Subjects (LCSH)
Manic-depressive illness
Psychoses--Treatment
Abstract
Paliperidone is most often used to treat psychosis. It may also be used to treat mania or depression. Symptoms paliperidone helps to relieve are reviewed. How quickly it starts working, how long to take it, possible side effects, and other general information is also given.
Responsibility
Prepared by: Pharmacy Services, QEII
Pamphlet Number
1938
Less detail

Quick Guide to Psychiatric Emergencies : Tools for Behavioral and Toxicological Situations

https://libcat.nshealth.ca/en/permalink/provcat43007
edited by Kimberly D. Nordstrom, Michael P. Wilson. --Cham, Switzerland: Springer , c2018.
Available Online
View e-Book
Location
Online
This volume provides an "on-the-go" guide to the most common behavioral emergencies a physician may encounter. Each chapter represents a disease state or symptom cluster and concisely summarizes the disease state, provides background, symptoms and signs, differential diagnoses, and immediate and long-term treatment options. All chapters conclude with a diagnosis or treatment algorithm or another easy-to-use visual tool. Chapters named after a specific disease state or symptom cluster, arranged …
Available Online
View e-Book
Other Authors
Nordstrom, Kimberly D.
Wilson, Michael P.
Responsibility
edited by Kimberly D. Nordstrom, Michael P. Wilson
Place of Publication
Cham, Switzerland
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (xviii, 292 p.) : 28 illus., 18 illus. in color
ISBN
9783319582603
9783319582580 (print ed.)
9783319582597 (print ed.)
Subjects (MeSH)
Emergencies
Emergency Services, Psychiatric - methods
Emergency Treatment - methods
Mental Disorders
Substance-Related Disorders
Specialty
Emergency Medicine
Psychiatry
Abstract
This volume provides an "on-the-go" guide to the most common behavioral emergencies a physician may encounter. Each chapter represents a disease state or symptom cluster and concisely summarizes the disease state, provides background, symptoms and signs, differential diagnoses, and immediate and long-term treatment options. All chapters conclude with a diagnosis or treatment algorithm or another easy-to-use visual tool. Chapters named after a specific disease state or symptom cluster, arranged alphabetically for use in the field. The text begins with chapters covering patient evaluation: getting a good history, suicide risk assessment, physical exam, and when and how to use studies. Written by experts in psychiatry and emergency medicine, this text is the first to consider both medical perspectives in a concise guide. Quick Guide to Psychiatric Emergencies is an excellent resource for psychiatrists, emergency medicine physicians, residents, nurses, and other medical professionals that handle behavioral emergencies on a regular basis.
Contents
Section I Evaluation Of Patients -- 1 Medical & Psychiatric History -- 2 Physical Exam -- 3 Laboratory Testing and Studies -- 4 Suicide Risk Assessment -- Section II Psychiatric Illness -- 5 Agitation -- 6 Anxiety -- 7 Catatonia -- 8 Depression -- 9 Mania -- 10 Psychosis -- Section III Medical Disorders -- 11 Adrenal Crisis -- 12 Chronic Pain -- 13 Delirium -- 14 Dementia -- 15 Encephalitis -- 16 Head Injury -- 17 Hepatic Encephalopathy -- 18 Hypercalcemia -- 19 Hypercortisolism -- 20 Hypoglycemia -- 21 Hyponatremia -- 22 Hypothyroidism -- 23 Myxedema Coma -- 24 Non-Epileptic Seizures -- 25 Seizures -- 26 Thyrotoxicosis -- 27 Wernicke-Korsakoff Syndrome -- Section IV Substance Intoxication -- 28 Acute Intoxication General Principles -- 29 Amphetamine Intoxication -- 30 Cocaine Intoxication -- 31 Ethanol Intoxication (Alcohol) -- 32 GHB Intoxication -- 33 Inhalant Intoxication -- 34 MDMA Intoxication -- 35 Opioid Intoxication -- 36 Psychedelic Intoxication -- Section V Withdrawal Syndromes -- 37 Acute Withdrawal General Principles -- 38 Alcohol Withdrawal -- 39 Amphetamine Withdrawal -- 40 Barbiturate Withdrawal -- 41 Benzodiazepine Withdrawal -- 42 Cannabis Withdrawal -- 43 Cocaine Withdrawal -- 44 Opioid Withdrawal -- Section VI Toxicologic Syndromes -- 45 Antidepressant Discontinuation Syndrome -- 46 Antimuscarinic Toxicity -- 47 Common Medications Which May Mimic Psychiatric Symptoms -- 48 Lithium Toxicity -- 49 Neuroleptic Malignant Syndrome -- 50 Salicylate Toxicity -- 51 Serotonin Syndrome -- 52 Steroid Psychosis -- 53 Valproic Acid Toxicity.
Format
e-Book
Location
Online
Less detail

Risperidone (Risperdal, Risperdal Consta)

https://libcat.nshealth.ca/en/permalink/chpams35648
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1639
Available Online
View Pamphlet
Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Risperidone
Subjects (LCSH)
Antipsychotic drugs
Specialty
Medications
Abstract
Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1639
Less detail

Welcome to the Mood Disorders Clinic

https://libcat.nshealth.ca/en/permalink/chpams36594
Nova Scotia Health Authority. Mood Disorders Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2017
Available Online
View Pamphlet
The Mood Disorders Clinic provides consultations for individuals with severe mood disorders, such as possible bipolar disorder. This is a specialized service to help diagnose and treat severe mood disorders. Mood disorders are a group of mental illnesses that affect how you feel and think about yourself, other people, and life in general. Two specific types of mood disorders we often see in the clinic are bipolar disorder and major depressive disorder. Topics include: bipolar disorder, symptoms…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Mood Disorders Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Mood Disorders - diagnosis
Mood Disorders - therapy
Bipolar Disorder
Depressive Disorder, Major
Subjects (LCSH)
Affective disorders--Diagnosis
Affective disorders--Treatment
Manic-depressive illness
Abstract
The Mood Disorders Clinic provides consultations for individuals with severe mood disorders, such as possible bipolar disorder. This is a specialized service to help diagnose and treat severe mood disorders. Mood disorders are a group of mental illnesses that affect how you feel and think about yourself, other people, and life in general. Two specific types of mood disorders we often see in the clinic are bipolar disorder and major depressive disorder. Topics include: bipolar disorder, symptoms of mania, symptoms of depression, major depressive disorder, causes of mood disorders, how mood disorders are treated, the clinical team, clinical treatment and services, the referral process, your first appointment, and followup care.
Responsibility
Prepared by: Mood Disorders Clinic
Pamphlet Number
2017
Less detail

18 records – page 1 of 1.